Literature DB >> 11984701

Increased bone resorption with decreased activity and increased recruitment of osteoblasts in osteogenesis imperfecta type I.

Jun Iwamoto1, Tsuyoshi Takeda, Shoichi Ichimura.   

Abstract

An iliac bone biopsy from an adult male, 58 years of age, with osteogenesis imperfecta type I was studied by bone histomorphometry after double-fluorescence labeling with tetracycline. Low bone mineral density (BMD) of the radius, measured by dual-energy X-ray absorptiometry (DXA) was associated with high levels of urinary deoxypyridinoline and serum bone-specific alkaline phosphatase and osteocalcin. At the tissue level, low cancellous bone volume (BV/TV) was associated with increased eroded surface (ES/BS) and a relatively increased osteoclast number (N.Oc/BS). Osteoid thickness (O.Th) was also decreased as a result of decreased bone matrix synthesis, in terms of decreased osteoblastic activity. However, osteoid surface (OS/BS) and osteoblast surface (ObS/BS), in terms of the number of osteoblasts, were increased. We conclude that the patient showed cancellous osteopenia, which was likely due to increased bone resorption with decreased activity and increased recruitment of osteoblasts.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11984701     DOI: 10.1007/s007740200025

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  6 in total

1.  Serum microRNA is a promising biomarker for osteogenesis imperfecta.

Authors:  Ziqiang Wang; Yanqin Lu; Xiumei Zhang; Xiuzhi Ren; Yanzhou Wang; Zhiliang Li; Chao Xu; Jinxiang Han
Journal:  Intractable Rare Dis Res       Date:  2012-05

2.  Accumulation of microdamage and low bone mass in the femoral head as a cause of subchondral insufficiency fracture in a patient with osteogenesis imperfecta.

Authors:  Ken Iwata; Tasuku Mashiba; Masashi Shimamura; Takanori Miki; Tetsuji Yamamoto
Journal:  J Bone Miner Metab       Date:  2019-05-11       Impact factor: 2.626

3.  Eleven years of experience with bisphosphonate plus alfacalcidol treatment in a man with osteogenesis imperfecta type I.

Authors:  Jun Iwamoto; Yoshihiro Sato; Mitsuyoshi Uzawa; Hideo Matsumoto
Journal:  Ther Clin Risk Manag       Date:  2012-12-28       Impact factor: 2.423

4.  A Clinical Perspective on Advanced Developments in Bone Biopsy Assessment in Rare Bone Disorders.

Authors:  Sanne Treurniet; Elisabeth M W Eekhoff; Felix N Schmidt; Dimitra Micha; Björn Busse; Nathalie Bravenboer
Journal:  Front Endocrinol (Lausanne)       Date:  2020-06-23       Impact factor: 5.555

5.  Compression Fractures and Partial Phenotype Rescue With a Low Phosphorus Diet in the Chihuahua Zebrafish Osteogenesis Imperfecta Model.

Authors:  Silvia Cotti; Ann Huysseune; Daria Larionova; Wolfgang Koppe; Antonella Forlino; Paul Eckhard Witten
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-24       Impact factor: 5.555

6.  Up-regulated IL-17 and Tnf signaling in bone marrow cells of young male osteogenesis imperfecta mice.

Authors:  Chenyi Shao; Yi Liu; Jiaci Li; Ziyun Liu; Yuxia Zhao; Yaqing Jing; Zhe Lv; Ting Fu; Zihan Wang; Guang Li
Journal:  PeerJ       Date:  2022-08-23       Impact factor: 3.061

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.